Checkpoint Therapeutics Inc (CKPT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2 GANSEVOORT STREET NEW YORK, NY 10014

Checkpoint Therapeutics, Inc. ('Checkpoint') is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-PD-L1 antibody licensed from the Dana-Farber Cancer Institute, in an ongoing global, open-label, multicohort Phase 1 clinical trial in checkpoint therapy-naïve patients with selected recurrent or metastatic cancers, including ongoing cohorts in locally advanced and metastatic cutaneous squamous cell carcinoma intended to support one or more applications for marketing approval. In addition, Checkpoint is evaluating its lead small-molecule, targeted anti-cancer agent, CK-101, a third-generation epidermal growth factor receptor ('EGFR') inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Checkpoint is headquartered in New York City and was founded by Fortress Biotech, Inc.

Data as of 2021-08-02 08:54:44 -0400
Market Cap189.843 Million Shares Outstanding72.184 Million Avg 30-day Volume861.029 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.08 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.31933 52-week High/Low5.38 / 1.9 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -34.0813
Data provided by IEX Cloud
View SEC Filings from CKPT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 71 64 10.94% 21 (1.23%) 18 (1.04%) 16.67%
13F shares: 15.606 Million 12.042 Million 29.59% 5.858 Million 2.594 Million 125.83%
% Ownership 22.8782 19.7787 15.67% 8.5885 4.2608 101.57%
New Positions: 15 17 -11.76% 6 6 0.0%
Increased Positions 26 29 -10.34% 6 6 0.0%
Closed Positions 8 8 0.0% 3 2 50.0%
Reduced Positions 18 8 125.0% 4 3 33.33%
Total Calls 13
Total Puts 6
PUT/CALL Ratio 0.46
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CKPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CKPT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SALZMAN BARRY M

  • Director
128,782 2021-06-10 1

HERSKOWITZ NEIL

  • Director
128,782 2021-06-10 1

BOILEN SCOTT

  • Director
151,004 2021-06-10 1

WEISS MICHAEL S

  • Director
78,782 2021-06-10 1

ROSENWALD LINDSAY A MD

  • Director
278,782 2021-06-10 1

BECHON CHRISTIAN

  • Director
102,334 2021-06-10 1

OLIVIERO JAMES F III CEO, PRESIDENT AND DIRECTOR

  • Officer
  • Director
3,153,210 2021-02-04 2

GRAY WILLIAM GARRETT CHIEF FINANCIAL OFFICER

  • Officer
482,170 2021-02-04 3

FORTRESS BIOTECH, INC.

  • 10% Owner
2,702,705 2017-03-17 0

HORIN DAVID J INTERIM CFO

  • Officer
0 2016-09-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BECHON CHRISTIAN - Director

2021-06-11 19:59:10 -0400 2021-06-10 A 16,502 a 102,334 direct -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

HERSKOWITZ NEIL - Director

2021-06-11 19:59:48 -0400 2021-06-10 A 16,502 a 128,782 direct -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

WEISS MICHAEL S - Director see note 3

2021-06-11 20:01:24 -0400 2021-06-10 A 16,502 a 78,782 indirect -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

ROSENWALD LINDSAY A MD - Director

2021-06-11 20:00:15 -0400 2021-06-10 A 16,502 a 278,782 direct -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

BOILEN SCOTT - Director

2021-06-11 20:01:48 -0400 2021-06-10 A 16,502 a 151,004 direct -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

SALZMAN BARRY M - Director

2021-06-11 20:00:44 -0400 2021-06-10 A 16,502 a 128,782 direct -4.4068 -6.4407 -10.1695 6.4407 21 -10.1695 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-03 14:45:04 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-03 14:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-03 13:45:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-03 13:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-03 12:45:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 22:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 21:45:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 21:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 20:45:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 20:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 19:45:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 19:15:03 UTC -0.8042 0.8642 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 18:45:03 UTC -0.7704 0.8304 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 18:15:03 UTC -0.7704 0.8304 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 17:45:03 UTC -0.7704 0.8304 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 17:15:03 UTC -0.7704 0.8304 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 16:45:03 UTC -0.772 0.852 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 16:15:03 UTC -0.772 0.852 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 15:45:03 UTC -0.772 0.852 3300000
CHECKPOINT THERAPEUTICS INC CKPT 2021-08-02 15:15:03 UTC -0.772 0.852 3300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments